Aerobic oxidations in flow: Opportunities for the fine chemicals and pharmaceuticals industries

© 2018 The Royal Society of Chemistry. Molecular oxygen is without doubt the greenest oxidant for redox reactions, yet aerobic oxidation is one of the most challenging to perform with good chemoselectivity, particularly on an industrial scale. This collaborative review (between teams of chemists and chemical engineers) describes the current scientific and operational hurdles that prevent the utilisation of aerobic oxidation reactions for the production of speciality chemicals and active pharmaceutical ingredients (APIs). The safety aspects of these reactions are discussed, followed by an overview of (continuous flow) reactors suitable for aerobic oxidation reactions that can be applied on scale. Some examples of how these reactions are currently performed in the industrial laboratory (in batch and in flow) are presented, with particular focus on the scale-up strategy. Last but not least, further challenges and future perspectives are presented in the concluding remarks. crosscheck: This document is CrossCheck deposited identifier: Simon Kuhn (ORCID) copyright_licence: The Royal Society of Chemistry has an exclusive publication licence for this journal copyright_licence: This article is freely available. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence (CC BY 3.0) history: Received 30 August 2016; Accepted 13 September 2016; Advance Article published 22 September 2016; Version of Record published 22 November 2016 ispartof: Reaction Chemistry & Engineering vol:1 issue:6 pages:595-612 status: published